Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.

NCT00168090 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00168090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.
Lead sponsor
CSL Behring
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2001
Completion date
May 31, 2006
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood coagulation disorders, blood platelet disorders, hematologic disease, von willebrand disease